The best and worst performing funds of 2021
Nick Sudbury runs through the 2021’s top picks and some funds that you would have been better off avoiding.
Nick Sudbury runs through the 2021’s top picks and some funds that you would have been better off avoiding.
Monetary policy is finally being tightened, but the markets are not pricing in the full extent of the measures needed to get inflation back under control.
Although not as well-known as its larger stablemate, Scottish Mortgage, Monks provides a great way to gain exposure to Baillie Gifford’s growth disrupters.
Some investment trusts don’t get the attention they deserve with Schroder Asian Total Return being a case in point; its strong track record and element of downside protection making it worth a closer look.
Real assets such as infrastructure are among the best ways to protect yourself against rising inflation with the returns from HICL going up with every increase in prices.
The latest updates from the various fund-of-funds can give some useful pointers as to where the managers are finding value.
It is not often that you come across an investment trust that is available for less than half of its net asset value (NAV), but this niche vehicle looks like it is materially undervalued.
Does Biotech Growth Trust’s recent share price weakness offer a decent entry point for long-term investors?
Looking back at bond yields over the last 40 years, all we see is a steep, never-ending decline, but is fixed income in the current climate?
A report by Investec looking at how the UK equity income sector held up during the lockdown has highlighted an advantage of close-ended funds.